We retrospectively analyzed our 2-year experience with venous access for 363 therapeutic plasma exchanges in 46 patients with neurological disease, including acute Guillain-Barrd syndrome (N = 20). myasthenia gravis (N = 17), and chronic inHammatory demyelinating polyneuropathy (N = 9). Twenty-three
Therapeutic plasma exchange in neurological diseases
β Scribed by Peter C. Dau; Tommie Wolff
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 144 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Neurologists commonly use therapeutic plasma exchange (TPE, also known as plasmapheresis or therapeutic apheresis) to treat a number of conditions. This concise review examines the most common neurologic indications for therapeutic plasma exchange. It focuses on GuillainβBarrΓ¨ syndrome
We wished to determine whether subtotal replacement of protein in plasma removed at plasma exchange would be adequate to prevent hypovolemia and hypoproteinemia. Seven well nourished outpatients with chronic progressive multiple sclerosis underwent 60 plasma exchanges in which two liters of plasma w
Graphite furnace atomic absorption spcctroscopy was used to demonstrate a fivefold increase in thc median plasma aluminium levcls of' four patients undergoing therapeutic plasmapheresis. This plasma aluminium loading resulted from contamination of albumin incorporated in the replacement fluids and t